NovaBay Pharmaceuticals Inc

Type: Company
Name: NovaBay Pharmaceuticals Inc
Nationality: United States
Web Address: http://www.novabaypharma.com/
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

NovaBay Pharmaceuticals to Present Successful Patient Case Histories of i-Lid Cleanser Use at the 2014 American Academy of Ophthalmology Meeting

At the annual AAO meeting, NovaBay will review numerous successful case histories detailing the growing successful use of i-Lid Cleanser for the management of common eye conditionsEMERYVILLE, CA / ACCESSWIRE /October 14, 2014 / NovaBay(R) Pharmaceuticals, ... [Published 4 Traders - Oct 14 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 6 reports

NovaBay Pharmaceuticals, Inc. Expands I-Lid Cleanser Market Reach With Addition To

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that NovaBay’s i-Lid™ Cleanser ... [Published BioSpace - Oct 09 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

Bio-Tissue’s Cliradex Kit Expands Lid-Care Line

Bio-Tissue, which specializes in regenerative tissue therapies and ocular hygiene products for lid margin and ocular surface diseases, has launched Cliradex Complete Advanced Lid Hygiene Kit, the newest addition to the Cliradex product line. These products ... [Published Review of Ophthalmology - Oct 06 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

BioNews [9.26.14]

Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ... [Published eClinical Trends - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 26 2014 - 7 reports

NovaBay awarded first large NeutroPhase order in China

Biopharmaceutical company NovaBay Pharmaceuticals (NYSE MKT:NBY) reported on Thursday the receipt of the first order of of 50,000 units for its NeutroPhase Skin and Wound Cleanser from its Chinese partner, China Pioneer Pharma Holdings (HK Stock Code:1345). ... [Published Individual.com - Sep 26 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Short Interest in NovaBay Pharmaceuticals Increases By 187.4% (NBY)

NovaBay Pharmaceuticals (NYSE:NBY) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 416,941 shares, a growth of 187.4% from the August 29th total of 145,082 ... [Published American Banking News - Forex - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

NovaBay creates advisory board

NovaBay Pharmaceuticals Inc. announced that it has created an Optometry Advisory Board to help oversee the development, marketing and medical use of NovaBay’s i-Lid Cleanser.The cleanser is designed to manage blepharitis and dry eye syndrome.The five ... [Published Orthopedics Today - Sep 24 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

NOVABAY PHARMACEUTICALS : Introduces Optometry Advisory Board

NovaBay Pharmaceuticals reported that it has created an Optometry Advisory Board to help oversee the development, marketing and medical use of NovaBay's i-Lid Cleanser and other eye care products.The five members of the new board are nationally known ... [Published 4 Traders - Sep 23 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 6 reports

NovaBay Pharmaceuticals, Inc. Creates Optometry Advisory Board

NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that it has created an Optometry Advisory Board to help oversee ... [Published BioSpace - Sep 18 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 3 reports

NovaBay Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Healthcare Conference

EMERYVILLE, Calif.--(EON: Enhanced Online News)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that Ron Najafi, ... [Published EON Business - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 3 reports

China’s Food and Drug Administration has Cleared NovaBay’s NeutroPhase Skin and Wound Cleanser for Sale throughout Mainland China by NovaBay’s Partner, China Pioneer Pharma

EMERYVILLE, Calif. & SHANGHAI--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, and China Pioneer Pharma Holdings, ... [Published Business Wire Photo/Multimedia News - Sep 03 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 5 reports

NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.

EMERYVILLE, Calif.--(EON: Enhanced Online News)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that its i-Lid ... [Published EON Communications - Aug 25 2014]

Quotes

...Ron Najafi, Chairman and CEO of NovaBay. "Once doctors hear about the results from using i-Lid Cleanser, we believe they will realize how much it can improve the management of many common eyelid conditions."
...brings a major increase in the number of eye doctors having convenient access to the product and in the number of patients who will benefit. "This is a tremendous opportunity for i-Lid Cleanser,” said Glenn Moro, NovaBay’s Vice President for Sales and Marketing. “Vision Source optometrists represent the largest concentration of optometrists in the country. This means i-Lid Cleanser will get into the hands of doctors that treat thousands of patients suffering from dry eye often associated with blepharitis."
"Garcia's story is a profile in courage," said Jacqueline Roemmele . "He is rebuilding his life after a terrible ordeal. But as NNFF's two other Hispanic heroes have demonstrated, it may be possible in the future to improve the outcomes from this terrible disease, making the consequences less devastating."
"The fact that five of the nation's top optometrists have agreed to serve on our new Optometry Advisory Board is evidence that i-Lid Cleanser is a breakthrough product that can make a real difference in patients' lives" said Dr. Najafi

More Content

All (68) | News (21) | Reports (0) | Blogs (47) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
NovaBay Pharmaceuticals to Present Successful P... [Published 4 Traders - Oct 14 2014]
NovaBay Pharmaceuticals, Inc. Expands I-Lid Cle... [Published BioSpace - Oct 09 2014]
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Fort Mills Times - Oct 09 2014]
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Wall Street Select - Oct 09 2014]
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire Photo/Multimedia News - Oct 09 2014]
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire News with Multimedia - Oct 09 2014]
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire Health News - Oct 09 2014]
Bio-Tissue’s Cliradex Kit Expands Lid-Care Line [Published Review of Ophthalmology - Oct 06 2014]
BioNews [9.26.14] [Published eClinical Trends - Sep 26 2014]
NovaBay awarded first large NeutroPhase order i... [Published Individual.com - Sep 26 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Fort Mills Times - Sep 25 2014]
NovaBay Reports Receiving of First Large Neutro... [Published Atlanta Journal And Constitution - Sep 25 2014]
NovaBay Reports Receiving of First Large Neutro... [Published Benzinga.com - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Photo/Multimedia News - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Health News - Sep 25 2014]
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire News with Multimedia - Sep 25 2014]
Short Interest in NovaBay Pharmaceuticals Incre... [Published American Banking News - Forex - Sep 25 2014]
Hispanic Heroes Honored in Fight Against "Flesh... [Published HispanicBusiness.com - Sep 24 2014]
NovaBay creates advisory board [Published Orthopedics Today - Sep 24 2014]
NOVABAY PHARMACEUTICALS : Introduces Optometry ... [Published 4 Traders - Sep 23 2014]
NovaBay Pharmaceuticals, Inc. Creates Optometry... [Published BioSpace - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Investor's Business Daily - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Fort Mills Times - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire Photo/Multimedia News - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire Health News - Sep 18 2014]
NovaBay Pharmaceuticals Creates Optometry Advis... [Published Business Wire News with Multimedia - Sep 18 2014]
BioNews [9.16.14] [Published eClinical Trends - Sep 16 2014]
NovaBay Pharmaceuticals Will Feature i-Lid Clea... [Published Investor's Business Daily - Sep 16 2014]
NovaBay Pharmaceuticals Will Feature i-Lid Clea... [Published Business Wire Health News - Sep 16 2014]
NovaBay Pharmaceuticals : Hispanic Heroes Honor... [Published 4 Traders - Sep 15 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire Photo/Multimedia News - Oct 09 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that NovaBay’s i-Lid™ Cleanser ...
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire News with Multimedia - Oct 09 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that NovaBay’s i-Lid™ Cleanser ...
NovaBay Expands i-Lid Cleanser Market Reach wit... [Published Business Wire Health News - Oct 09 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that NovaBay’s i-Lid™ Cleanser ...
BioNews [9.26.14] [Published eClinical Trends - Sep 26 2014]
Top News HeadlineCompanyType Pharmacyclics and Servier Agree to Conclude Pan-HDAC Inhibitor Collaboration Pharmacyclics & ServierEnded Collaboration This Switch Could Make Gilead Sciences, Inc. Stock Billions Gilead Sciences, Inc.Block ...
NovaBay Receives First Large NeutroPhase Order ... [Published Business Wire Photo/Multimedia News - Sep 25 2014]
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China Pioneer ...
1 2 3 4 5 6 7 8 9 10
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.